Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity. - Institut Agro Rennes-Angers Accéder directement au contenu
Article Dans Une Revue Nutrition, Metabolism and Cardiovascular Diseases Année : 2008

Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity.

F. Paillard
  • Fonction : Auteur
F. Le Duff
  • Fonction : Auteur
M. Bouriel
  • Fonction : Auteur
Y. Deugnier
  • Fonction : Auteur
M. Pouchard
  • Fonction : Auteur
J. C. Daubert
  • Fonction : Auteur

Résumé

BACKGROUND AND AIM: In an animal model VLDL-triglyceride secretion is highly dependent on stearoyl-coA desaturase (SCD) activity and could explain abdominal fattening. The aim was to assess the relationship of plasma palmitoleic acid content, a product of SCD activity, with triglyceridemia and abdominal adiposity in humans. METHODS: We evaluated 134 healthy men. Plasma palmitoleic acid content was used as an indirect measurement of SCD activity because that enzyme catalyzes the desaturation from saturated to monounsaturated fatty acids and palmitoleic acid intake is very small. RESULTS: Subjects with triglycerides > or =75th percentile had a higher palmitoleic acid content than those with triglycerides <75th percentile (3.8+/-0.8 vs 2.8+/-0.9%, p<0.0001). Triglyceridemia was strongly correlated with palmitoleic acid content (PAC) (r=0.533, p<0.001). Mean triglyceridemia was 114% higher (1.43+/-0.75 vs 0.67+/-0.22 mmol/l) in the fourth quartile than in the first quartile of palmitoleic acid content. In a stepwise logistic regression analysis, palmitoleic acid content was the most strongly and independently associated parameter with triglyceridemia, and also with waist circumference when triglyceridemia was not included in the analysis. CONCLUSION: Plasma palmitoleic acid content, a product of SCD activity, is an independent marker of triglyceridemia and abdominal adiposity in men. This enzyme (SCD) could represent a target for prevention and treatment of these metabolic disorders in particular in subjects at risk of developing a metabolic syndrome.

Dates et versions

hal-00729782 , version 1 (07-09-2012)

Identifiants

Citer

F. Paillard, Daniel D. Catheline, F. Le Duff, M. Bouriel, Y. Deugnier, et al.. Plasma palmitoleic acid, a product of stearoyl-coA desaturase activity, is an independent marker of triglyceridemia and abdominal adiposity.. Nutrition, Metabolism and Cardiovascular Diseases, 2008, 18 (6), pp.436-40. ⟨10.1016/j.numecd.2007.02.017⟩. ⟨hal-00729782⟩
39 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More